Free Trial
NYSEARCA:IBRN

iShares Neuroscience and Healthcare ETF (IBRN) Price, Holdings, & News

iShares Neuroscience and Healthcare ETF logo
$26.75
-0.24 (-0.89%)
(As of 10/31/2024 ET)

About iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN)

Key Stats

Today's Range
$26.75
$26.75
50-Day Range
$24.07
$27.62
52-Week Range
$19.09
$27.62
Volume
8 shs
Average Volume
671 shs
Market Capitalization
$4.01 million
Assets Under Management
$4.05 million
Dividend Yield
0.06%
Net Expense Ratio
0.47%
Aggregate Rating
Moderate Buy

ETF Overview

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.

iShares Neuroscience and Healthcare ETF Expenses

TypeIBRNTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.47%0.57%0.55%0.51%0.52%
Other Expenses0.00%0.57%0.49%0.58%0.53%
Total Expense0.47%0.73%0.71%0.73%0.71%
Fee Waiver0.00%-0.74%-0.52%-0.68%-0.57%
Net Expense0.47%0.59%0.61%0.58%0.59%
Receive IBRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

IBRN ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com

IBRN ETF - Frequently Asked Questions

iShares Neuroscience and Healthcare ETF's stock was trading at $26.23 at the start of the year. Since then, IBRN shares have increased by 2.0% and is now trading at $26.7482.
View the best growth stocks for 2024 here
.

Shares of IBRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Fund Details

Issuer
iShares
Fund Name
iShares Neuroscience and Healthcare ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:IBRN
Inception Date
8/24/2022
Fund Manager
Jennifer Hsui, Greg Savage, Paul Whitehead, Amy Whitelaw
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE FactSet Global Neuro Biopharma and MedTech Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
66

Fund Statistics

Assets Under Management
$4.05 million
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Flow Traders

Options

Optionable
N/A
Short Interest
300 shs

Miscellaneous

Beta
1.06
Creation Unit
50,000
Creation Fee
$350.00
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Top 10 IBRN Holdings

IBRN Sector Exposure

IBRN Industry Exposure


This page (NYSEARCA:IBRN) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners